← FDA Drug Approvals (Drugs@FDA)

CASPOFUNGIN ACETATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2017-09-29

Drug application

FDA Application #

ANDA207092

Application type

Abbreviated New Drug Application (Generic)

Brand name

CASPOFUNGIN ACETATE

Generic name

CASPOFUNGIN ACETATE

Active ingredients

CASPOFUNGIN ACETATE

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

GLAND

Manufacturer

Sagent Pharmaceuticals

First approval

2017-09-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown